🧪 Lab Sheet: Hepion to Debut on OTCQB Venture Market June 25 as “HEPA”

iBio (IBIO) reports its engineered amylin-receptor antibody slashed food intake 60% in obese-mouse trials, matching advanced DACRA peptide results.

Brooks Dyroff&Casimir Stone

Jun 26, 2025

One trade idea here could pay for your subscription 10x.

We don’t cover fluff. We cover ideas that move portfolios. Upgrade now, before you miss your next trade